NASDAQ | ETF
Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) inU. S. securities demonstrating positive momentum.
The fund defines positive momentum as having positive returns for the previous one-, three-, six-, or twelve-month period or returns greater than the investment universe for the previous one-, three-, six-, or twelve-month period.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ORCL | Oracle Corporation | Technology | Software - Infrastructure | 3.90% |
| NEM | Newmont Goldcorp Corp | Basic Materials | Gold | 3.86% |
| WDC | Western Digital Corporation | Technology | Computer Hardware | 3.84% |
| MP | MP Materials Corp | Basic Materials | Other Industrial Metals & Mining | 3.81% |
| MU | Micron Technology Inc | Technology | Semiconductors | 3.73% |
| LRCX | Lam Research Corp | Technology | Semiconductor Equipment & Materials | 3.71% |
| DDS | Dillard's, Inc. | Consumer Cyclical | Department Stores | 3.71% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 3.68% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 3.65% |
| TER | Teradyne Inc | Technology | Semiconductor Equipment & Materials | 3.65% |
| CHRW | CH Robinson Worldwide Inc | Industrials | Integrated Freight & Logistics | 3.62% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.62% |
| TSCO | Tractor Supply Company | Consumer Cyclical | Specialty Retail | 3.59% |
| AMAT | Applied Materials Inc | Technology | Semiconductor Equipment & Materials | 3.56% |
| W | Wayfair Inc | Consumer Cyclical | Internet Retail | 3.55% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 3.55% |
| RF | Regions Financial Corporation | Financial Services | Banks - Regional | 3.54% |
| GOOGL | Alphabet Inc Class A | Communication Services | Internet Content & Information | 3.52% |
| TNL | Travel + Leisure Co | Consumer Cyclical | Travel Services | 3.52% |
| ROIV | Roivant Sciences Ltd | Healthcare | Biotechnology | 3.49% |